Cyber Monday SaleUp to 60% OFF
Markets India Stocks Health Technology Pharmaceuticals: Generic

IND SWIFT LABS INDSWFTLAB

INDSWFTLAB NSE
INDSWFTLAB
IND SWIFT LABS NSE
See more on advanced chartSee more on advanced chart
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

INDSWFTLAB Stock Chart

Get $150 worth of Bitcoin from TradeStation Crypto with a new account. Start trading

Ideas

Videos only
Expecting Breakout ✌✌
INDSWFTLAB
, 1D
Long
INDSWFTLAB: Expecting Breakout ✌✌

This scrip is expected to give trendline breakout as it is on the verge of breakout. So traders keep on your rdar to catch the momentum and enjoy the profit. Thanks to all.

INDSWFTLAB buy position
INDSWFTLAB
, 240
Long
INDSWFTLAB: INDSWFTLAB buy position

Possible Breakout with a strong uptrend.

INDSWFT M TF
INDSWFTLAB
, 1M
Long
INDSWFTLAB: INDSWFT M TF

INDSWFT LOOKING GOOD CUP AND HANDLE PATTERN ON MONTHLY HOLD POSITION STOPLOSS @80 TARGET 130- 140

IndSwift Lab- Cup and HANDLE - Breakout
INDSWFTLAB
, 1D
Long
INDSWFTLAB: IndSwift Lab- Cup and HANDLE - Breakout

Positional Trade: Indswift Lab breaks out of a cup and handle pattern. Buy: Indswift Lab CMP: 98 Target: 109-110 Stop Loss: 88

INDSWFTLAB, waiting for breakout
INDSWFTLAB
, 1M
Long
INDSWFTLAB: INDSWFTLAB, waiting for breakout

Target 165 SL around 55 Time frame 3 years

Buy Ind Swift Lab
INDSWFTLAB
, 1D
Long
INDSWFTLAB: Buy Ind Swift Lab

My idea is for educational purpose. This Pharma stock is yet to perform. Buy Ind Swift lab @80 for short term gain of 10-20%.

INDSWFTLAB
INDSWFTLAB
, 1W
Long
INDSWFTLAB: INDSWFTLAB

buy above 85 closing tgt 110

indswftlab cp 61.15
INDSWFTLAB
, 1D
Long
INDSWFTLAB: indswftlab cp 61.15

not for real tred.

The volume is encouraging
INDSWFTLAB
, 1D
Long
INDSWFTLAB: The volume is encouraging

Support 93, 94 Target 107, 122

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Pharmaceuticals: Generic
Ind-Swift Laboratories Ltd. engages in the manufacture, development, and market of pharmaceutical ingredients. The firm operates through In India and Outside India geographical segments. Its products include API's and impurities. The firm supplies active pharmaceutical ingredients to pharmaceutical companies and also provides research and development services. The company was founded on January 4, 1995 and is headquartered in Manimajra, India.

Breaking news

More news